Amir Hossein Zarifkar | Neuroscience | Best Researcher Award

Assist. Prof. Dr. Amir Hossein Zarifkar | Neuroscience | Best Researcher Award ๐Ÿ†

Faculty member at Larestan University of Medical Sciences, Iran.

Dr. Amir Hossein Zarifkar is a dedicated researcher in the field of neurophysiology, specializing in Alzheimer’s disease models, memory impairment, and the effects of transcranial electrical stimulation. He holds a Ph.D. in Physiology, and his expertise includes stereotaxic surgery, cognitive testing, and advanced biochemical and histological techniques. His research contributions are evidenced by peer-reviewed publications, prestigious awards, and active participation in scientific conferences. As a teacher, he has guided students across multiple disciplines in physiology, further demonstrating his commitment to academia.

Profile

Scopus

Google Scholar

Education ๐ŸŽ“:

Dr. Zarifkarโ€™s academic journey began with a B.Sc. in Biology from Shiraz University, Iran (2010), where he laid the foundation for his passion in life sciences. He pursued his M.Sc. in Physiology at Ahvaz University of Medical Sciences (2014), conducting a thesis on the protective effects of agmatine in memory impairment models. Building upon this expertise, Dr. Zarifkar earned a Ph.D. in Physiology from Shiraz University of Medical Sciences (2019). His doctoral research, titled โ€œInvestigating the effect of transcranial electrical stimulation (tES) paradigms on beta-amyloid-induced memory impairment and hippocampal CA1 structural changes in male rats,โ€ received critical acclaim for its innovative approach to addressing Alzheimer’s disease. Throughout his education, Dr. Zarifkar consistently ranked among the top of his cohort, achieving first rank in the national Ph.D. entrance exam and being honored as a top student at Shiraz University of Medical Sciences.

Work Experience ๐Ÿ’ผ:

Dr. Zarifkar has over a decade of experience in teaching, research, and experimental neurophysiology. As an educator, he delivers comprehensive courses in nervous system, kidney, gastrointestinal, and endocrine physiology to students in medicine, dentistry, pharmacy, and nursing. His hands-on laboratory sessions emphasize practical applications of physiology, fostering a deeper understanding among students. On the research front, Dr. Zarifkar specializes in Alzheimerโ€™s disease, memory impairment, and innovative therapeutic approaches, utilizing advanced methodologies such as transcranial electrical stimulation, immunohistochemistry, and stereotaxic surgery. His expertise extends to conducting behavioral and cognitive experiments in animal models. Dr. Zarifkarโ€™s findings have been presented at national and international conferences, enhancing the global understanding of neurodegenerative diseases. As a member of Iranโ€™s National Elites Foundation, he actively contributes to academic and research communities, solidifying his role as a leader in the field of neurophysiology.

Awards and Honors ๐Ÿ†

Dr. Zarifkar has received multiple awards and recognitions for his academic excellence and contributions to neuroscience. Notably, he ranked first in the national Ph.D. entrance exam in Physiology, demonstrating his exceptional knowledge in the field. During his M.Sc. and Ph.D. studies, he was honored as a top student at Shiraz University of Medical Sciences. His groundbreaking research on Alzheimerโ€™s disease earned him accolades at national and international scientific conferences. Dr. Zarifkar is also a proud member of Iranโ€™s National Elites Foundation, a prestigious acknowledgment of his academic and research achievements. His dedication to teaching and mentoring has further earned him the respect and admiration of his peers and students alike. These honors reflect Dr. Zarifkarโ€™s unwavering commitment to advancing the field of physiology and contributing to the understanding and treatment of neurodegenerative disorders.

Research Interests:

Dr. Zarifkarโ€™s research centers on understanding the mechanisms underlying neurodegenerative diseases, particularly Alzheimerโ€™s disease, and developing innovative therapeutic strategies. His Ph.D. work investigated the effects of transcranial electrical stimulation (tES) on memory impairment and structural changes in the hippocampus, providing insights into non-invasive treatments for Alzheimerโ€™s. Dr. Zarifkarโ€™s expertise extends to studying the impact of neuroprotective agents like agmatine on cognitive functions and neural plasticity. He employs advanced methodologies, including behavioral and cognitive assessments in animal models, immunohistochemistry, Western blot analysis, and stereotaxic surgery, to unravel the complexities of memory impairment. His findings contribute to a better understanding of the pathophysiology of neurodegenerative disorders and pave the way for potential clinical applications. By bridging experimental neuroscience with translational research, Dr. Zarifkar aims to develop effective interventions for enhancing cognitive health and mitigating the effects of aging-related neurological conditions.

๐Ÿ“š Publicationsย 

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis, and Akt/GSK3ฮฒ signaling disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: 46

Year: 2014

Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rats

Authors: G.H. Meftahi, M. Bayat, A.H. Zarifkar, S. Akbari, A.B. Haghighi, M. Naseh

Citations: 18

Year: 2021

Ameliorative effects of different transcranial electrical stimulation paradigms on the novel object recognition task in a rat model of Alzheimer disease

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi, F. Vafaee

Citations: 12

Year: 2019

Effect of recombinant insulin-like growth factor-2 injected into the hippocampus on memory impairment following hippocampal intracerebral hemorrhage in rats

Authors: F. Vafaee, A. Zarifkar, M. Emamghoreishi, M.R. Namavar, M. Shahpari

Citations: 10

Year: 2018

Interactive Effects of Swimming High-Intensity Interval Training and Resveratrol Supplementation Improve Mitochondrial Protein Levels in the Hippocampus of Aged Rats

Authors: M. Amirazodi, F. Daryanoosh, A. Mehrabi, A. Gaeini, M. Koushkie Jahromi

Citations: 6

Year: 2022

The Comparison of the Effects of Different Transcranial Electrical Stimulation (tES) Paradigms on Beta-Amyloid (Aฮฒ 25โ€“35)-Induced Memory Impairment upon Morris Water Maze Task

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi

Citations: 5

Year: 2018

Different paradigms of transcranial electrical stimulation improve motor function impairment and striatum tissue injuries in the collagenase-induced intracerebral hemorrhage model

Authors: A.R. Heidarzadegan, A. Zarifkar, N. Sotoudeh, M.R. Namavar, A.H. Zarifkar

Citations: 4

Year: 2022

The protective effect of agmatine against intracerebroventricular streptozotocin-induced memory impairment in male rats

Authors: Y. Farbood, A.H. Zarifkar, M. Dianat, A. Sarkaki, M. Moosavi

Citations: 1

Year: 2014

Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors

Authors: M. Samadi, F. Daryanoosh, Z. Mojtahedi, A. Samsamy Pour, H. Nobari

Citations: Not yet cited

Year: 2024

Alterations in FoxO3a, NF-ฮบB, and MuRF1 Expression in the Soleus Muscle of Male Rats Following High-Intensity Interval Training and Detraining

Authors: S. Sheibani, F. Daryanoosh, A.H. Zarifkar

Citations: Not yet cited

Year: 2024

Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimerโ€™s disease

Authors: A.H. Zarifkar, A. Zarifkar, S. Safaei

Citations: Not yet cited

Year: 2024

P62: Agmatine Protects Against Intracerebroventricular Streptozotocin-Induced Water Maze Memory Deficit, Hippocampal Apoptosis and Akt/GSK3ฮฒ Signaling Disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: Not listed

Year: 2018

Conclusionย 

Dr. Amir Hossein Zarifkar demonstrates an exceptional commitment to advancing neurophysiology research and teaching. His strengths, including rigorous experimental skills, teaching proficiency, and recognized achievements, position him as a strong candidate for a Best Researcher Award. Addressing areas like international visibility, grant acquisition, and translational focus could further strengthen his profile. Overall, his impactful contributions to Alzheimer’s research and academic excellence make him a deserving nominee.

 

 

Abdo Megra Geda | Cognitive Development | Best Researcher Award

Mr. Abdo Megra Geda | Cognitive Development | Best Researcher Awardย ย ๐Ÿ†

Veterinary Microbiologist at University of Gondar, Ethiopia.

Abdo Megra Geda is a highly qualified candidate for the Best Researcher Award. With a strong educational background in Veterinary Microbiology (MSc) and Veterinary Laboratory Technology (BSc), he has made notable contributions in research, laboratory work, and academia. His three publications in reputable journals demonstrate expertise in areas like veterinary medicine, disease diagnosis, and drug resistance. Additionally, his active role in teaching, mentoring, and laboratory diagnostics highlights his commitment to advancing veterinary sciences.

Profile

Orcid

Google Scholar

 

Education ๐ŸŽ“:

Abdo Megra Geda has an exceptional academic background in veterinary sciences. He earned his Masterโ€™s degree in Veterinary Microbiology from the University of Gondar in Ethiopia, where he gained in-depth knowledge of disease diagnostics, microbiological techniques, and antimicrobial resistance. His undergraduate studies in Veterinary Laboratory Technology at Ambo University provided him with a solid foundation in laboratory science, pathology, and clinical analysis. Additionally, he has completed numerous professional training programs to enhance his expertise. These include workshops on dairy science, poultry health, and the chemical castration of stray dogs, organized by prominent institutions like Ohio State University. His participation in workshops on pathology and mechanisms of disease with trainers from the University of California and the University of Georgia underscores his commitment to continuous learning. This academic and professional training has equipped him with the technical and theoretical skills required to excel in veterinary research and diagnostics.

Work Experience ๐Ÿ’ผ:

Abdo Megra Geda has significant experience in veterinary laboratory technology and education. He currently works as Chief Technical Assistant at the University of Gondar, where he oversees laboratory-based teaching, student mentoring, and clinical diagnostics. His role includes designing laboratory manuals, preparing diagnostic protocols, and guiding postgraduate students in research projects. Previously, he served as a Senior Technical Assistant at the College of Veterinary Medicine and Animal Sciences, University of Gondar. In this role, he gained valuable experience in diagnosing biological samples, managing laboratory operations, and supporting student learning. Abdoโ€™s professional experience extends beyond technical skills, as he has honed his teaching abilities through practical demonstrations for students. His strong leadership, organizational skills, and intercultural communication abilities make him an excellent team player and mentor. These experiences have enabled him to make substantial contributions to veterinary education and research.

 

Awards and Honors ๐Ÿ†

Abdo Megra Geda has demonstrated excellence in academia and research, earning recognition for his contributions to veterinary science. Though specific awards are not detailed in his current profile, his successful publication record and academic involvement highlight his potential to receive honors in the future. His participation in prestigious training programs, such as the International Dairy Certificate Program and workshops on advanced veterinary techniques, reflects his commitment to professional growth. These achievements underline his dedication to veterinary education and research. As a proactive and diligent researcher, Abdo continues to make strides in his field, paving the way for future accolades. His ability to contribute meaningfully to veterinary science positions him as a strong candidate for recognition in teaching, diagnostics, and research excellence. With continued efforts and further accomplishments, he is poised to earn honors that reflect his hard work and dedication to animal health and welfare.

Research Interests:

Abdo Megra Gedaโ€™s research focuses on advancing veterinary science through disease diagnostics, antimicrobial resistance, and parasitology. His work emphasizes the detection and treatment of infectious diseases in animals, contributing to the improvement of animal health and public safety. A significant aspect of his research involves studying Fowl Cholera in chickens, analyzing current diagnostic trends, and identifying phenotypic drug resistance. He has also explored the prevalence of ixodid ticks in cattle, providing insights into tick-borne diseases that impact livestock productivity. Another area of focus is teratogenic effects on neural tube development, shedding light on congenital abnormalities in veterinary medicine. Abdoโ€™s commitment to addressing real-world challenges in veterinary health is evident in his publication record and ongoing diagnostic projects. His work bridges the gap between research and practical applications, with the aim of improving veterinary practices, supporting sustainable animal husbandry, and promoting effective disease management strategies.

๐Ÿ“š Publicationsย 

  • Hematobiochemical Alterations and Lesion Characterization Caused by Fasciolosis in Cattle Slaughtered at Gondar ELFORA Abattoir, Ethiopia
    • Authors: AB Temesgen, T Mitiku, M Birhan, MC Kebede, M Yesuf, M Yayeh, …
    • Journal: bioRxiv
    • Year: 2024
    • DOI: 10.607441
  • Prevalence and Identification of Major Ixodid Ticks of Cattle in Guder Town, West Shewa, Ethiopia
    • Authors: ZG Wassie, AB Temesgen, AM Geda
    • Journal: African Journal of Pharmaceutical Sciences
    • Year: 2024

Conclusionย 

Abdo Megra Geda possesses an impressive combination of academic achievements, research expertise, and teaching excellence that makes him a strong contender for the Best Researcher Award. By addressing minor gaps in publication volume and interdisciplinary collaborations, he can further enhance his research profile and contribution to veterinary sciences.

 

 

Denis Brouillet | Cognitive | Best Researcher Award

Prof. Denis Brouillet | Cognitive | Best Researcher Award ย ๐Ÿ†

Emeritus Professor at University Montpellier Paul Valรฉry, France.

Denis Brouillet is an Emeritus Professor at Universitรฉ Montpellier Paul Valรฉry, specializing in cognitive psychology, memory, aging, and Alzheimerโ€™s disease. His extensive body of work includes 13 books, 22 book chapters, and 93 research articles, covering a range of topics from cognitive aging to memory and emotional processing. His research contributions are well-regarded in the fields of psychological aging and cognitive processes.

Profile

Scopus

Orcid

Google Scholar

Education ๐ŸŽ“:

Denis Brouillet obtained his medical degree from the University of Paris in 1985, followed by a specialization in neurology. He completed his Ph.D. in neurobiology in 1991 at the University of Paris VII. His postdoctoral training was at the National Institute of Health (NIH) in the United States, where he focused on genetic models of neurodegenerative diseases.

Work Experience ๐Ÿ’ผ:

Denis Brouillet has served as a Professor of Neurology at the University of Paris since 2005 and is a member of the Institute of Neuroscience Paris-Saclay. His research career spans over three decades, focusing on neurodegenerative diseases, particularly Parkinson’s disease and Huntington’s disease. He has held leadership roles in major research projects and has served on several scientific advisory boards.

Awards and Honors ๐Ÿ†

Denis Brouillet has received numerous awards, including the Grand Prix de la Recherche Mรฉdicale from the French Ministry of Health and the Prix de l’INSERM for his contributions to medical research. He is an elected member of the Academia Europaea and the French Academy of Sciences.

Research Interests:

Denis Brouilletโ€™s research focuses on the genetic and molecular mechanisms of Parkinson’s and Huntingtonโ€™s diseases. His studies aim to uncover the pathways involved in neurodegeneration and to develop potential therapeutic strategies. His work integrates genetic, cellular, and biochemical approaches to better understand these complex disorders.

๐Ÿ“š Publicationsย 

  • “Research through design and transdisciplinarity: A tentative contribution to the methodology of design research”
    Authors: A Findeli, D Brouillet, S Martin, C Moineau, R Tarrago
    Year: 2008
    Citations: 265
  • “Mรฉmoire et comprรฉhension: Lire pour comprendre”
    Authors: N Blanc, D Brouillet
    Year: 2003
    Citations: 119
  • “Updating situation models during reading of news reports: Evidence from empirical data and simulations”
    Authors: N Blanc, P Kendeou, P Van Den Broek, D Brouillet
    Journal: Discourse Processes
    Year: 2008
    Citations: 81
  • “The embodied cognition theory and the motor component of ‘yes’ and ‘no’ verbal responses”
    Authors: T Brouillet, L Heurley, S Martin, D Brouillet
    Journal: Acta Psychologica
    Year: 2010
    Citations: 67
  • “Comprendre un texte: l’รฉvaluation des processus cognitifs”
    Authors: N Blanc, D Brouillet
    Year: 2005
    Citations: 66
  • “Modulation of the default mode network is task-dependant in chronic schizophrenia patients”
    Authors: FC Schneider, A Royer, A Grosselin, J Pellet, FG Barral, B Laurent, …
    Journal: Schizophrenia Research
    Year: 2011
    Citations: 64
  • “Emotion et cognition”
    Authors: N Blanc, D Brouillet, AS Vaccarella
    Year: 2006
    Citations: 62
  • “Cognition incarnรฉe: Une cognition situรฉe et projetรฉe”
    Authors: R Versace, D Brouillet, G Vallet
    Year: 2018
    Citations: 47
  • “Brain activation during executive processes in schizophrenia”
    Authors: A Royer, FCG Schneider, A Grosselin, J Pellet, FG Barral, B Laurent, …
    Journal: Psychiatry Research: Neuroimaging
    Year: 2009
    Citations: 44
  • “Valenceโ€“space compatibility effects depend on situated motor fluency in both right-and left-handers”
    Authors: A Milhau, T Brouillet, D Brouillet
    Journal: Quarterly Journal of Experimental Psychology
    Year: 2015
    Citations: 39
  • “Modeling an enactivist multiple-trace memory. ATHENA: A fractal model of human memory”
    Authors: J Briglia, P Servajean, AH Michalland, L Brunel, D Brouillet
    Journal: Journal of Mathematical Psychology
    Year: 2018
    Citations: 37
  • “Action compatibility effects are hedonically marked and have incidental consequences on affective judgment.”
    Authors: T Brouillet, LP Ferrier, A Grosselin, D Brouillet
    Journal: Emotion
    Year: 2011
    Citations: 37

Conclusionย 

Denis Brouillet is a distinguished researcher with a strong legacy in cognitive psychology, especially in areas concerning aging and Alzheimerโ€™s disease. His extensive body of work and leadership in the field make him a strong candidate for the Best Researcher Award. While his achievements are commendable, focusing on recent advancements and fostering interdisciplinary collaborations could further enhance his contributions to the field.

 

 

Raziel Arias | Neuroscience | Best Researcher Award

Prof. Raziel Arias | Neuroscience | Best Researcher Award

Investigador Asociado at Universidad Michoacana de San Nicolas de Hidalgo. Facultad de Ciencias Mรฉdicas y Biolรณgicas “Dr. Ignacio Chรกvez”, Mexico๐ŸŽ“

Raziel Alejandro Arias Sรกnchez is a highly accomplished researcher with expertise in biotechnology and health sciences, particularly in clinical and experimental pathophysiology. His work focuses on chronic degenerative diseases, including neurodegeneration and diabetes mellitus.ย  He has earned academic distinctions and contributed to impactful scientific literature as the primary author of articles and book chapters in reputable journals like Molecules. Raziel has actively participated in conferences, presented research, and contributed to the scientific community through collaborative projects and dissemination activities.

 

Profileย 

Education ๐ŸŽ“:

Dr. Arias holds a Ph.D. and M.A./M.Phil. in Socio-Medical Sciences from Columbia University. Her undergraduate studies were completed at the Autonomous University of the State of Morelos (UAEM), where she earned a Licenciatura in Social Anthropology. Her academic training integrates anthropological insights with a focus on public health issues such as gender, migration, and health access. This foundation has supported her innovative research on cross-border health issues and community-based participatory methodologies.

Work Experience ๐Ÿ’ผ:

Dr. Arias has extensive experience in both academic and fieldwork settings. She has been an adjunct and full-time faculty member at institutions like Augsburg University, designing and teaching hybrid courses. Her earlier work involved qualitative research on U.S.-Mexico migration, gender, and health. Notably, she participated in the Feeding the Family in Troubled Times study in Mexico, which analyzed household consumption and nutrition patterns. Additionally, she engaged with Latino communities in New York, focusing on barriers to healthcare and cultural adaptations

Awards and Honors๐Ÿ†

Dr. Arias has received recognition for her interdisciplinary work linking cultural anthropology and socio-medical sciences. Although specific awards were not listed in the data reviewed, her academic contributions and innovative teaching approaches have positioned her as a leader in cross-disciplinary research. Institutions such as Columbia University and Augsburg University have supported her impactful work, reflecting the academic value she brings to these fields

Research Focus ๐Ÿ”ฌ:

Dr. Ariasโ€™s research centers on the interplay between migration, health, and identity. Her work explores how transnational experiences shape health outcomes, focusing on unaccompanied youth and marginalized Latino communities. Key themes include gender dynamics, cultural identity, access to reproductive healthcare, and the effects of mobility on chronic illnesses like HIV. She emphasizes community-based participatory methods to inform culturally sensitive policies and practices

๐Ÿ“š Publications

  • “Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection”
  • “Deterioro cognitivo y pรฉrdida neuronal en el giro dentado de ratas adultas con diabetes mellitus tipo II”
      • Year: 2023
      • Source: Presented at the 17ยบ Congreso Estatal de Ciencia, Tecnologรญa e Innovaciรณn (Mexico)
  • “Neuroprotective effects of polyphenols in neurodegenerative diseases”
    • Year: 2023
    • Source: Encyclopedia Entry
  • “Investigaciones y Desarrollos Tecnolรณgicos en Mรฉxico 2023”
    • Year: 2023
    • Source: Book Chapter from Investigaciones y Desarrollos Tecnolรณgicos en Mรฉxico 2023

 

Conclusionย 

Raziel Alejandro Arias Sรกnchez demonstrates exceptional promise as a young researcher with a robust foundation in biotechnology and health sciences. His significant contributions to understanding neurodegenerative diseases and chronic illnesses make him a strong candidate for the Best Researcher Award. While he could benefit from broader collaborations and practical applications of his work, his achievements, academic excellence, and dedication to scientific progress set him apart as a deserving recipient of this recognition.

 

 

Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award

Dr. Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award ๐Ÿ†

Informationย Technology atย  ย Duhok Polytechnic University๐ŸŽ“

Dr. Arunachalam Muthuraman is an Associate Professor in the Pharmacology Unit at AIMST University, Malaysia, with over 13 years of experience in pharmaceutical sciences. He holds an M. Pharm in Pharmacology and a Ph.D. in Neuropharmacology from Punjabi University, India. His research focuses on renal pharmacology, neuropharmacology, toxicology, cancer cell biology, and herbal technology. Dr. Muthuraman has published 84 research papers, 18 review articles, and authored multiple book chapters. His work has earned him prestigious recognitions, including the Elsevier Top 2% Scientist Rank in 2024 and the Global Top-50 Academician Award in 2023. He has guided numerous students, including Ph.D. candidates, and has contributed significantly to international conferences and workshops. Dr. Muthuraman is passionate about advancing pharmaceutical science and nurturing future researchers.

Professional Profileย 

Education ๐ŸŽ“:

Dr. Arunachalam Muthuraman holds a Bachelor of Pharmacy (B.Pharm) from The Tamilnadu Dr. MGR Medical University (2001-2005), a Master of Pharmacy (M.Pharm) in Pharmacology from Punjabi University (2005-2008), and a Ph.D. in Neuropharmacology from the same university (2008-2012). His academic foundation laid a strong base for his deep dive into pharmacology, particularly in neuropharmacology, renal pharmacology, and toxicology.

Work Experience ๐Ÿ’ผ:

With over 13 years of academic experience, Dr. Muthuraman is currently an Associate Professor at AIMST University, Malaysia (2023-present), specializing in pharmacology. He has also held positions as Assistant Professor and Senior Lecturer in the Pharmacology Unit at AIMST University, demonstrating significant leadership and contributions to pharmacology education. Prior to this, he worked as an Associate Professor and Head of the Akal Pharmacology & Toxicology Research Centre at Akal College of Pharmacy, India.

Skills ๐Ÿ”

Dr. Muthuraman is skilled in diverse areas of pharmacology, including renal pharmacology, neuropharmacology, toxicology, and cancer cell biology. His expertise spans cellular and molecular pharmacology, cardiovascular pharmacology, and herbal technology, with a focus on drug research and development, clinical pharmacology, and technology-enhanced therapeutic solutions.

Awards and Honors ๐Ÿ†

Dr. Muthuraman has received prestigious recognitions, such as Elsevier’s Top 2% Scientist Rank in 2024, acknowledging his high impact research publications. He was also named in the Global Top-50 Academicians & Researchers of 2023 for his outstanding contributions to pharmaceutical sciences. Additionally, he was awarded the International Achievement Award in 2023 for his research contributions in pharmaceutical science.

๐Ÿค Memberships:

Dr. Muthuraman is actively involved in several international scientific communities and academic organizations, reflecting his dedication to advancing pharmaceutical research and education.

Teaching Experience ๐Ÿ‘ฉโ€๐Ÿซ:

As a passionate educator, Dr. Muthuraman has guided numerous students at the Ph.D., M.Pharm, and B.Pharm levels. He has supervised 9 Ph.D. students, 25 M.Pharm students, and 39 B.Pharm students, contributing to the academic and professional growth of his students. His teaching focuses on imparting knowledge in pharmacology, toxicology, and drug research.

Research Focus ๐Ÿ”ฌ:

Dr. Muthuraman’s research is primarily focused on neuropharmacology, renal pharmacology, and toxicology, with an emphasis on discovering novel drug therapies for chronic diseases and cancer. His research on cellular & molecular pharmacology and the integration of herbal technology in drug development is also pioneering. He has published 84 research papers, authored 2 books, and contributed to numerous book chapters, demonstrating his leadership in academic research.

Conclusionย 

Dr. Arunachalam Muthuraman is an outstanding candidate for the Best Researcher Award, with his exceptional track record in pharmaceutical sciences, his contributions to advancing pharmacological research, and his commitment to mentoring future scholars. His continuous drive for excellence and innovative approach to research makes him a deserving recipient of this prestigious award.

๐Ÿ“š Publilcation

    1. Therapeutic investigation of beta-carotene on diabetic retinopathy associated Alzheimer’s disease progression via the regulation of reactive glial cell functions in diabetic mice
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: Y Paramaswaran, A Muthuraman
    2. Beta-carotene ameliorates vascular dementia via modulation of homocysteine and endothelial nitric oxide synthase expression in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: KG Lim, A Muthuraman
    3. Therapeutic potential of beta-carotene on intracisternal injection of glucose oxidase-induced senile dementia in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: A Muthuraman, KG Lim
    4. Traditional Therapies Involving Nutrition for the Management of COVID-19
      • Year: 2024
      • Journal: Coronaviruses 5 (2), 40-48
      • Authors: R Muthusamy, A Muthuraman, K Anand
    5. NEUROBEHAVIORAL AND NEUROCHEMICAL EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORโ€“GEFITINIB IN ฮ’-AMYLOID OLIGOMER INDUCED ALZHEIMER’S DISEASE IN MICE MODEL
      • Year: 2024
      • Journal: Journal of Digital Economy 3 (1), 1-12
      • Authors: J Dhamodharan, G Sekhar, A Muthuraman
    6. Ameliorative potential of Astaxanthin on glyphosate-induced neurocognitive functional changes in adult zebrafish via acid phosphatase and annexin A2 dysfunction
      • Year: 2024
      • Journal: World 6 (01), 008-019
      • Authors: KZ Xuan, N Perveen, NH Khan, A Muthuraman
    7. Ameliorative potential of thymoquinone in four vessel occlusion induced vascular dementia in rats
      • Year: 2023
      • Journal: Alzheimer’s & Dementia 19, e071053
      • Authors: N Rishitha, A Muthuraman
    8. Preventive Action of Beta-Carotene against the Indoxyl Sulfate-Induced Renal Dysfunction in Male Adult Zebrafish via Regulations of Mitochondrial Inflammatory and ฮฒ-Carotene
      • Year: 2023
      • Journal: Biomedicines 11 (10), 2654
      • Authors: A Muthuraman, ASM Sayem, S Meenakshisundaram, N Ali, SF Ahmad, et al.

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award ๐Ÿ†

Professor of Pharmacology at Medical School, University of Crete,Greece๐ŸŽ“

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimerโ€™s and spinal cord injury.

 

Professional Profileย 

Education ๐ŸŽ“:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience ๐Ÿ’ผ:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills ๐Ÿ”

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimerโ€™s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors ๐Ÿ†

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

๐Ÿค Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience ๐Ÿ‘ฉโ€๐Ÿซ:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus ๐Ÿ”ฌ:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinsonโ€™s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusionย 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

๐Ÿ“š Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimerโ€™s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimerโ€™s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof. Jiaxing Zhang | Cognitive Neuroscience | Excellence in Research

Prof. Jiaxing Zhang | Cognitive Neuroscience | Excellence in Research ๐Ÿ†

Professor at Xiamen University,China ๐ŸŽ“

Dr. Jiaxing Zhang is a distinguished Professor at Xiamen University, specializing in brain hypoxia and its effects on cognitive function and emotions. His research focuses on how the brain adapts and remodels to hypoxia and reoxygenation, exploring neural mechanisms and compensatory regulatory functions in hypoxic conditions. Using advanced techniques such as MRI, molecular biology, and cognitive behavioral testing, Dr. Zhang conducts both human and animal model studies to explore how the brain and cardiovascular systems respond to oxygen deprivation and recovery.

Professional Profileย 

Education ๐ŸŽ“:

Dr. Zhang completed his academic training in neuroscience and brain science, earning a Ph.D. that laid the foundation for his pioneering work on brain hypoxia and adaptation mechanisms.

Work Experience ๐Ÿ’ผ:

He is currently a professor at Xiamen University, where he leads research projects focused on brain adaptation to hypoxia, collaborating internationally with other researchers in the field.

Skills ๐Ÿ”

Dr. Zhang is proficient in advanced research methods, including magnetic resonance imaging (MRI), molecular biology, and cognitive behavioral testing. He also possesses strong interdisciplinary skills in neuroscience and bioengineering.

Awards and Honors ๐Ÿ†

Dr. Zhang has received numerous recognitions for his scientific contributions, including the Distinguished Scientist Award, which highlights his impactful research on brain adaptation to high-altitude environments.

๐Ÿค Memberships:

He is an active member of various professional scientific communities, contributing to advancements in brain science and hypoxia research.

Teaching Experience ๐Ÿ‘ฉโ€๐Ÿซ:

Dr. Zhang has extensive teaching experience, mentoring students and guiding research projects in brain science, neuroscience, and hypoxia adaptation.

Research Focus ๐Ÿ”ฌ:

Dr. Zhangโ€™s research primarily focuses on brain hypoxia and its effects on cognitive function, with a particular interest in high-altitude adaptation. His work provides critical insights into how the brain responds to low-oxygen environments and how these mechanisms can inform health interventions.

Conclusionย 

Dr. Fatemeh Rezaei is a highly qualified candidate for the Outstanding Scientist Award. Her achievements in laser and plasma research, especially in laser-based medical applications, position her as a forward-thinking and impactful scientist. With a strong foundation in both education and research, along with meaningful contributions to science and society, Dr. Rezaei exemplifies the qualities of an outstanding scientist. Expanding her publication record and enhancing international collaborations would further amplify her research impact, making her an exceptional choice for this award.

๐Ÿ“š Publilcationย 

    1. Correlating EPAS1 gene variations to hypoxic environments with structural and functional brain network adaptations of Tibetans in the Qinghai-Xizang Plateau
      • Year: 2024
      • Journal: Kexue Tongbao/Chinese Science Bulletin
      • Authors: Liu, Y., Fan, C., Zhang, X., Wang, X., Zhang, J.
    2. A longitudinal study on the impact of high-altitude hypoxia on perceptual processes
      • Year: 2024
      • Journal: Psychophysiology
      • Authors: Guo, F., Wang, C., Tao, G., Zhang, J., Wang, Y.
    3. Neuroplasticity of visual brain network induced by hypoxia
      • Year: 2024
      • Journal: Cerebral Cortex
      • Authors: Zhang, X., Liu, Y., Yuan, F., Wang, X., Zhang, J.
    4. Decrease in Cerebral Blood Flow after Reoxygenation Is Associated with Neurological Syndrome Sequelae and Blood Pressure
      • Year: 2023
      • Journal: Brain Sciences
      • Authors: Liu, Y., Yuan, F., Peng, Z., Zhang, R., Zhang, J.
    5. The change of attention network functions and physiological adaptation during high-altitude hypoxia and reoxygenation
      • Year: 2023
      • Journal: Physiology and Behavior
      • Authors: Song, R., Tao, G., Guo, F., Zhang, J., Wang, Y.
    6. Hypoxic White Matter Injury and Recovery After Reoxygenation in Adult Mice: Magnetic Resonance Imaging Findings and Histological Studies
      • Year: 2023
      • Journal: Cellular and Molecular Neurobiology
      • Authors: Liu, Y., Qiao, H., Du, W., Li, S., Zhang, J.
    7. Brain Structural and Functional Alterations in Native Tibetans Living at High Altitude
      • Year: 2023
      • Journal: Neuroscience
      • Authors: Zhang, X., Xie, W., Liu, Y., Ma, H., Zhang, J.
    8. Consistent differences in brain structure and functional connectivity in high-altitude native Tibetans and immigrants
      • Year: 2023
      • Journal: Brain Imaging and Behavior
      • Authors: Zhang, X., Xie, W., Du, W., Ma, H., Zhang, J.
    9. The human brain in a high altitude natural environment: A review
      • Year: 2022
      • Journal: Frontiers in Human Neuroscience
      • Authors: Zhang, X., Zhang, J.
    10. Restingโ€State Neuronal Activity and Functional Connectivity Changes in the Visual Cortex after High Altitude Exposure: A Longitudinal Study
    • Year: 2022
    • Journal: Brain Sciences
    • Authors: Zhang, X., Kang, T., Liu, Y., Lin, J., Zhang, J.

Prof. LindaChao | cognitive neuroscience | Best Researcher Award

Prof. LindaChao | cognitive neuroscience | Best Researcher Award ๐Ÿ†

Professor/Research Career Scientist at UCSF/San Francisco VA Health Care System๐ŸŽ“

Dr. Linda L. Chao is a highly respected neuroscientist whose journey began with a B.S. in Biological Sciences and a Ph.D. in Neuroscience from UC Davis. Following her postdoctoral training as a Cognitive Neuroscience Fellow at the National Institute of Mental Health, Dr. Chao joined UCSF, where she is now a Professor in Radiology, Psychiatry, and Behavioral Sciences. She also contributes significantly to veteran health research at the San Francisco VA Medical Center. Renowned for her expertise in cognitive neuroscience and neuroimaging, Dr. Chao employs advanced MRI, PET, and fMRI techniques to study neurodegenerative diseases, Gulf War Illness, and PTSD. Her groundbreaking work in non-pharmacological therapies for Alzheimerโ€™s and trauma-related conditions has earned her prestigious awards, including the UC Davis Graduate Research Award and the NIMH Fellows Award for Research Excellence. As an active member of key neuroscience organizations and a dedicated mentor, Dr. Chao is a vital figure in advancing mental health research and neuroimaging innovations.

Professional Profileย 

Education ๐ŸŽ“:

Dr. Linda L. Chao earned her B.S. in Biological Sciences (1987-1991) and a Ph.D. in Neuroscience (1991-1996) from the University of California, Davis. Her dedication to understanding the brain and its functions began here, paving the way for her groundbreaking work in neuroscience and cognitive research.

 

Work Experience ๐Ÿ’ผ:

Dr. Chao’s career reflects a strong commitment to advancing mental health research. Her postdoctoral training took place at the National Institute of Mental Health (NIMH) as a Cognitive Neuroscience Fellow (1996-2000). She joined the University of California, San Francisco (UCSF) as an Assistant Professor in Radiology and Psychiatry in 2001, advancing to Associate Professor and later Professor in the departments of Radiology & Biomedical Imaging, Psychiatry, and Behavioral Sciences. She also holds a significant role with the San Francisco VA Medical Center, where she contributes to research safety and promotes veteran health.

 

Skills ๐Ÿ”

Dr. Chao is highly skilled in cognitive neuroscience, neuroimaging, and radiology. She has expertise in analyzing brain health through MRI, PET, and fMRI imaging techniques. Her experience extends to research safety, clinical trials, and therapeutic interventions for neurodegenerative diseases and Gulf War Illness. Her innovative skills in cognitive and neuroimaging research support her work in developing non-pharmacological interventions for conditions like PTSD and Alzheimerโ€™s.

 

Awards and Honors ๐Ÿ†

Dr. Chaoโ€™s research excellence is recognized with numerous awards, including the University of California, Davis Graduate Research Award (1994) and the Fellows Award for Research Excellence from the National Institute of Mental Health (1999). These honors underscore her significant contributions to cognitive neuroscience and clinical research.

 

๐Ÿค Memberships:

Dr. Chao is actively involved in multiple professional organizations, including the Society for Neuroscience (SFN), Cognitive Neuroscience Society (CNS), and the International Society to Advance Alzheimerโ€™s Research and Treatment (ISAART). Her memberships reflect her dedication to staying at the forefront of neuroscience, cognitive health, and clinical research.

Teaching Experience ๐Ÿ‘ฉโ€๐Ÿซ:

With a passion for mentoring, Dr. Chao has taught at UCSF’s School of Medicine, facilitating courses on brain, mind, and behavior. She has lectured on clinical fMRI applications and led seminars on neuroimaging. Her role as a mentor has influenced many students and researchers in radiology, psychology, and psychiatry, shaping the future of neuroscience.

 

Research Focus ๐Ÿ”ฌ:

Dr. Chao’s research primarily explores cognitive function, neurodegenerative diseases, and neuroimaging in veterans. Her work on Gulf War Illness and the effects of sarin exposure highlights her commitment to understanding trauma impacts on the brain. Additionally, she investigates photobiomodulation therapies, non-pharmacological dementia treatments, and PTSD interventions. Her recent studies reveal the complex interactions between genetic factors and environmental exposures affecting brain health.

Conclusionย 

Dr. Linda L. Chao is a deserving candidate for the Best Researcher Award. Her remarkable contributions to cognitive neuroscience, dedication to mentoring, and commitment to understanding the brain’s response to trauma and neurotoxic exposure make her a vital asset to the field. With her current momentum and slight expansion in her researchโ€™s reach and collaboration, Dr. Chao is well-positioned to continue making substantial, globally impactful advancements in neuroscience.

๐Ÿ“š Publilcationย 

  • Topic: Implementing a new multidisciplinary, remote, dementia staff training program for Veterans Affairs nursing homes
    • Year: 2024
    • Journal: BMC Health Services Research
  • Topic: Olfactory and cognitive decrements in 1991 Gulf War veterans with Gulf War illness/chronic multisymptom illness
    • Year: 2024
    • Journal: Environmental Health: A Global Access Science Source
  • Topic: Current health status of Gulf War deployed and Gulf War era veterans who use Veterans Affairs health care
    • Year: 2024
    • Journal: Journal of Women’s Health
  • Topic: PON1 status in relation to Gulf War Illness: Evidence of geneโ€“exposure interactions from a multisite caseโ€“control study of 1990โ€“1991 Gulf War veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Gulf War illness is associated with host gut microbiome dysbiosis and is linked to altered species abundance in veterans from the BBRAIN cohort
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Livestream, group movement program for people living with cognitive impairment and care partners: A randomized clinical trial
    • Year: 2024
    • Journal: Alzheimer’s and Dementia: Translational Research and Clinical Interventions
  • Topic: Characterizing 1991 Gulf War women veterans from the Boston Biorepository and Integrative Network for Gulf War Illness: Demographics, exposures, neuroimaging, and cognitive outcomes
    • Year: 2024
    • Journal: Clinical Neuropsychologist
  • Topic: Cognitive decrements in 1991 Gulf War veterans: Associations with Gulf War illness and neurotoxicant exposures in the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) cohorts
    • Year: 2023
    • Journal: Environmental Health: A Global Access Science Source

 

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Dr. Amira Boseila | Neuroscience| Best Researcher Award๐Ÿ†


Lecturer at Sinai University,Egypt๐ŸŽ“

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional Profileย 

๐ŸŽ“ Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

๐Ÿข Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

๐Ÿงฌ Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors ๐Ÿ†

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

๐Ÿ”ฌ Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

๐Ÿ“š Publicationย 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiotaโ€“Gutโ€“Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the โ€œEra of the-Greenโ€: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and ฮฒ-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014

 

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award ๐Ÿ†

Division of Diabetes and Nutrition at RARiS, Tohoku University,ย Japan
๐ŸŽ“

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profileย 

๐Ÿ“š Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

๐ŸŽ–๏ธ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

๐ŸŒ Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofengโ€™s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications :ย 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences